Visanu Thamlikitkul
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 76
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance 59
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 40
-
- Nosocomial Infections in ICU 22
- Endocrinology top 0.5%
-
- Pneumonia and Respiratory Infections 34
-
- Pharmaceutical and Antibiotic Environmental Impacts 24
-
- Bacterial Identification and Susceptibility Testing 17
-
- Antimicrobial Resistance in Staphylococcus 12
- Co-authors
- Jian LiRoger L. NationAlan ForrestSurapee TiengrimRujipas SirijatuphatFernanda P. SilveiraSamira M. GaronzikDavid L. Paterson
- Journals
- The Lancet (1 paper)SHILAP Revista de lepidopterología (5 papers)PLoS ONE (5 papers)
- Partner nations
- ThailandUnited StatesSouth Korea
In The Last Decade
Visanu Thamlikitkul
201 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Molecular Medicine 3.4k
- Applied Microbiology and Biotechnology 1.3k
- Pharmacology 2.2k
- Critical Care and Intensive Care Medicine 629
- Endocrinology 579
Countries citing papers authored by Visanu Thamlikitkul
This map shows the geographic impact of Visanu Thamlikitkul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Visanu Thamlikitkul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Visanu Thamlikitkul more than expected).
Fields of papers citing papers by Visanu Thamlikitkul
This network shows the impact of papers produced by Visanu Thamlikitkul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Visanu Thamlikitkul. The network helps show where Visanu Thamlikitkul may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Visanu Thamlikitkul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 12 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 7 | |
| 6 | Comparative Effectiveness and Safety of Original Gabapentin and Generic Gabapentin in Treating Patients with Neuropathic Pain at Siriraj Hospital, Bangkok, Thailand | 2020 | 1 |
| 7 | Monitoring of Effectiveness and Safety of Colistin for Therapy in Resistant Gram-Negative Bacterial Infections in Hospitalized Patients at Siriraj Hospital. | 2016 | 11 |
| 8 | Accuracy of ICD-10 Coding System for Identifying Comorbidities and Infectious Conditions Using Data from a Thai University Hospital Administrative Database. | 2016 | 9 |
| 9 | Implementation of antibiotic use guidelines for fresh traumatic wound at Siriraj Hospital. | 2015 | 4 |
| 10 | STOP Antimicrobial Resistance: Everybody’s Business | 2014 | 3 |
| 11 | Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital. | 2013 | 3 |
| 12 | Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. | 2012 | 18 |
| 13 | 2011 | 19 | |
| 14 | Microbiological equivalence of bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving generic piperacillin/tazobactam (Pipertaz) and original piperacillin/tazobactam (Tazocin). | 2011 | 1 |
| 15 | Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital. | 2011 | 6 |
| 16 | Microbiological equivalence of serum bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving original meropenem (Meronem) and generic meropenem (Mero). | 2010 | 2 |
| 17 | 2009 | 95 | |
| 18 | Effectiveness of the Royal Thai Traditional Massage for Relief of Muscle Pain | 2006 | 2 |
| 19 | Clinical Study of Morus Alba Linn. on Glycemic Control and Blood Lipids in Patients with Type 2 Diabetes: A Preliminary Study | 2006 | 2 |
| 20 | Use of Alternative Medicines among Medical Patients at Siriraj Hospital | 2002 | 2 |
About Visanu Thamlikitkul
Visanu Thamlikitkul is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 206 papers that have together received 6.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (76 papers), Antibiotic Use and Resistance (59 papers), Antibiotics Pharmacokinetics and Efficacy (40 papers), Pneumonia and Respiratory Infections (34 papers), Pharmaceutical and Antibiotic Environmental Impacts (24 papers), Nosocomial Infections in ICU (22 papers), Bacterial Identification and Susceptibility Testing (17 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). The work is most often cited by research in Molecular Medicine (3.4k citations), Applied Microbiology and Biotechnology (1.3k citations) and Pharmacology (2.2k citations). Visanu Thamlikitkul has collaborated with scholars based in Thailand, United States and South Korea. Frequent co-authors include Jian Li, Roger L. Nation, Alan Forrest, Surapee Tiengrim, Rujipas Sirijatuphat, Fernanda P. Silveira, Samira M. Garonzik, David L. Paterson, Po‐Ren Hsueh and Pinyo Rattanaumpawan. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.